Infection for Helicobacter pylori in patient with gastritis of policlinic Reynold Garc?a
Keywords:
gastritis, Helicobacter pylori, endoscopia superior digestiveAbstract
Introduction: Helicobacter pylori plays a key role in the development of digestive diverse diseases such as the chronic gastritis, the peptic ulcer, the gastric cancer and the gastric MALT lymphoma, so its timely diagnosis is essential. Methods: A retrospective, descriptive study was carried out in 337 patients assisted in the consultation of Gastroenterology of Policlinic Reynold Garc?a, of Matanzas, during 20152019, with diagnostic endoscopic and gastritis histologic, to those that were carried out urease test to confirm the infection for Helicobacter pylori. For the obtaining of the information the reports endoscopic were revised; the obtained data were picked up in a schedule created by the authors and they were captured in charts for better understanding. The biopsies wereArchivos Cubanos de Gastroenterolog?a. 2021;2(1):e34
?
?
analyzed in the Military Hospital Mario Mu?oz, previous coordination with the address of the center. Results: 337 patients were studied, 62.6% of them male and 37.4% female. Clinically, epigastric pain (93.1%) and gastric filling (36.7%), prevailed as the main reason for the indication of the endoscopy. Nodular antral gastritis (72.4%) turned out to be the main endoscopic diagnosis found and acute gastritis was observed in a greater number of patients (57.7%), as a histological diagnosis. The age group most affected by Helicobacter pylori was 25 to 34 years (35.8%) and males (44.2%). Conclusions: Male patients aged 25 to 34 were the most infected with Helicobacter pylori. Epigastric pain and gastric fullness were the main symptoms that motivated the endoscopic procedure. Nodular antral gastritis prevailed as endoscopic diagnosis and acute gastritis as the main histological diagnosis. A statistically significant association was found between male sex and nodular gastritis with the presence of H. pylori infection.
Downloads
References
Cuba. MINSAP. Anuario estadístico Oficina Nacional de Estadísticas e Información, Republica de Cuba. La Habana: MINSAP; 2018.
Miranda Moles Zulma, Mulet Pérez Agustín M, Gámez Escalona Martha M, Escobar Bernal Alfredo, Rodríguez Diéguez Margarita, López Almaguer Gustavo. Gastritis crónica antral por Helicobacter pylori en pacientes con y sin consumo de antiinflamatorios no esteroideos. ccm [Internet]. 2015 Mar [citado 2019 Ene 08]; 19(1): 63-75. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S156043812015000100007&lng=es
Ahire D, Alston T, Raffaniello R. Variations in the multimerization region of the Helicobacter pylori cytotoxin CagA affect virulence. Oncol Lett. 2017 Mar;13(3):1444-50.
Bernardini G, Figura N, Ponzetto A, Marzocchi B, Santucci A. Application of proteomics to the study of Helicobacter pylori and implications for the clinic. Expert Rev Proteomics. 2017 May 26:1-14.
Avalos García R, Morales Díaz M. Romero Bareira SR, Laud Martínez PM. Comportamiento del cáncer gástrico avanzado diagnosticado por videoendoscopia en el Hospital “Faustino Pérez Hernández”, Matanzas. Rev Méd Electrón [Internet].2017 May-Jun [citado: fecha de acceso];39(3). Disponible en:
http://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/2072/3441
Graham DY, Laine L. The Toronto Helicobacter pylori Consensus in Context. Gastroenterology 2016; 151: 9-12.
Stollman N. Helicobacter pylori infection in the era of antibiotic resistence. Gastroenterol Hepatol 2016; 2: 122-25.
Gisbert JP, Romano M, Gravina AG, Solis-Muñoz P, Bermejo F, MolinaInfante J, et al. Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments. Aliment Pharmacol Ther. 2015;41(8):768-75.
Fallone CA, Chiba N, van Zanten SV, Fischbach L, et al. The Toronto Consensus for the Treatment of Helicobacter pylori Infection in Adults. Gastroenterology 2016; 151: 51-69
Kang WM, Meng QB, Yu JC, Ma ZQ, Li ZT. Factors associated with early recurrence after curative surgery for gastric cancer. World J Gastroenterol 2015; 21(19): 5934-40. Disponible en: http://www.wjgnet.com/1007-9327/full/v21/i19/5934.htm
Malfertheiner P, Megraud F, et al. Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut 2017; 66:6-30.
Ortega JP, Espino A, Calvo A, Verdugo P, Pruyas M, Nilsen E, et al. Infección por Helicobacter pylori en pacientes sintomáticos con patología gastroduodenal benigna: Análisis de 5.664 pacientes. Rev Med Chile. 2017; 138:529-35.
Gisbert H, Diagnostico de la infección por Helicobacter pylori. [Revista online] Madrid, 2015.200(7): 370-2. Disponible en http://www.revclinesp.es/es/diagnostico-infeccion-por-helicobacter pylori/articulo/10017061/
Choi JM, Kim SG, Choi JM, et al. Effects of Helicobacter pylori eradication for metachronous gastric cáncer prevention: a randomized controlled trial. Gastrointest Endosc. 2018; 88:475-85.
Duquesne Alderete A, Orellana Molina Y. Caracterización clínico-epidemiológica-endoscópica-anatomopatológica y microbiológica de pacientes con gastritis. Policlínico 19 de Abril. 2012-2016. Panorama Cuba y Salud.2017; 12 (3):39-45.
Underwood FE, Tanyingoh D, et al. Global Prevalence of Helicobacter pylori infection: Systematic Review and metaanalysis. Gastroenterology 2017; 153:420-29.
Jung YS, Park CH, Park JH, Nam E, Lee HL. Efficacy of Helicobacter pylori eradication therapies in Korea: A systematic review and network metaanalysis. Helicobacter 2017; 22:e12389.
Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG Clinical Guideline: Treatment of Helicobacter pylori Infection. Am J Gastroenterol 2017; 112:212-39.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Archivos Cubanos de Gastroenterolog?a

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
La revista reconoce a las personas que firman como autores siempre y cuando estos cumplan con los criterios establecidos universalmente para los autores de los art?culos cient?ficos. Regularmente se solicitar? a los autores de art?culos originales, env?en la declaraci?n de autor?a firmada por cada uno de ellos y donde se explique su rol dentro de la investigaci?n. El comit? editorial se reserva el derecho de aceptar determinados autores en relaci?n con el rol declarado y la envergadura de la investigaci?n.
Esta revista protege los Derechos de autor desde el mismo momento en que se realiza el env?o. Sin embargo, cede parte de los derechos patrimoniales de autor al exhibir una licencia Creative Commons 4.0 (cc-by-nc), que permite el uso de la obra para compartir (copiar y redistribuir el material en cualquier medio o formato) y adaptar (remezclar, transformar y construir a partir del material) siempre y cuando se haga menci?n exclusiva a la publicaci?n en la revista como fuente primaria. ?Sin embargo, no podr? comercializar con ella.
?